BioCentury
ARTICLE | Financial News

OncoGenex planning follow-on

October 19, 2010 1:02 AM UTC

OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI) said late Monday it plans to sell units in a follow-on underwritten by Stifel Nicolaus Weisel; Needham; Rodman; and Wedbush. Each unit will comprise a share and a five-year warrant to purchase 0.5 shares. Further details were not disclosed. ...